Abvida-M 50/1000

Description

Abvida-M 50/1000 Eazy Glide Tablet SR is an oral antidiabetic combination medicine from Abbott, containing Metformin (1000 mg) and Vildagliptin (50 mg). It is specially formulated as a sustained-release (SR) tablet to provide a gradual release of medicine, ensuring stable blood sugar control throughout the day.

It is prescribed for the management of Type 2 Diabetes Mellitus in adults, particularly in patients whose blood sugar is not adequately controlled by diet, exercise, or single-agent therapy.

• Metformin (1000 mg) is a biguanide that lowers glucose production in the liver, slows glucose absorption in the gut, and improves the body’s sensitivity to insulin.

• Vildagliptin (50 mg) is a DPP-4 inhibitor that increases insulin release and reduces glucagon secretion, thereby lowering both fasting and post-meal blood glucose levels.

Together, they offer complementary mechanisms of action, providing more effective control of diabetes, while reducing the risks of long-term complications such as kidney damage, eye problems, nerve damage, heart disease, and stroke.

The tablet is taken with food to reduce stomach upset and should be swallowed whole without crushing or breaking. It works best when taken regularly at the same time each day, along with a healthy diet, regular exercise, and weight management.

Common side effects may include nausea, dizziness, headache, trembling, gastroesophageal reflux, and upper respiratory infections. Hypoglycemia (low blood sugar) may occur, especially if used with insulin or sulfonylureas, so patients should learn to recognize early warning signs like sweating, shakiness, or dizziness.

Safety considerations:

• Kidney: Use with caution; dose adjustment may be required.

• Liver: Not recommended in patients with liver disease.

• Pregnancy & Breastfeeding: Use only if prescribed by a doctor, as safety data is limited.

• Alcohol: Should be avoided, as it increases the risk of lactic acidosis and hypoglycemia.

• Driving: Caution is advised if blood sugar fluctuations affect concentration or alertness.

In conclusion, Abvida-M 50/1000 Eazy Glide Tablet SR provides powerful dual therapy with a sustained release action, ensuring effective and consistent blood sugar management for patients with type 2 diabetes, while lowering the risk of long-term complications when combined with proper lifestyle measures.